This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ajinomoto Co., Ltd.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Akira Otaka: Innovator in Peptide Chemistry
Introduction
Akira Otaka is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of peptide chemistry, particularly in the production of peptide compounds. His innovative methods have the potential to advance various applications in biochemistry and pharmaceuticals.
Latest Patents
One of Akira Otaka's key patents is titled "Method for producing peptide hydrazide, peptide amide, and peptide thioester." The objective of this invention is to provide a method for producing peptide thioester compounds, peptide hydrazide compounds, and peptide amide compounds. The method utilizes a compound represented by a specific formula and employs a hydrazine compound or an ammonia compound as a reaction reagent. This innovative approach also outlines a process for producing peptide thioester compounds from peptide hydrazide compounds.
Career Highlights
Akira Otaka is associated with Ajinomoto Co., Ltd., a leading company in the food and biotechnology sectors. His work at Ajinomoto has allowed him to focus on peptide synthesis and its applications in various industries. His contributions have been recognized within the scientific community, showcasing his expertise in peptide chemistry.
Collaborations
Throughout his career, Akira Otaka has collaborated with esteemed colleagues, including Akira Shigenaga and Masakazu Sugiyama. These collaborations have fostered a productive environment for research and innovation in peptide-related technologies.
Conclusion
Akira Otaka's work in peptide chemistry exemplifies the impact of innovative methods in scientific research. His patent on peptide production highlights the importance of advancements in this field. His contributions continue to influence the development of new applications in biochemistry and pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
